Megan Boston's Insider Trades & SAST Disclosures
Megan Boston's most recent trade in Benitec Biopharma Inc was a trade of 720,000 Options (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Megan Boston.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Benitec Biopharma Inc | Megan Boston | Director, Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 720,000 | 720,000 | - | - | Options (right to buy) | |
| Benitec Biopharma Inc | Megan Boston | Director, Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 200,004 | 200,004 | - | - | Options (right to buy) | |
| Benitec Biopharma Inc | Megan Boston | Director, Executive Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2023 | 25,907 | 25,907 | - | - | Common Warrants (right to buy) | |
| Benitec Biopharma Inc | Megan Boston | Director, Executive Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Aug 2023 | 25,907 | 25,907 | - | - | Common Stock | |
| Benitec Biopharma Inc | Megan Boston | Director, Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 153,000 | 153,000 | - | - | Options (right to buy) | |
| Benitec Biopharma Inc | Megan Boston | Director, Executive Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 142,172 | 142,172 | - | - | Options (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges